These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 28601887

  • 1. Comparative Retinal Vessel Size Study of Intravitreal Ranibizumab and Bevacizumab in Eyes with Neovascular Age-Related Macular Degeneration.
    Kurt MM, Çekiç O, Akpolat Ç, Aslankurt M, Elçioğlu MN.
    Ophthalmologica; 2017; 238(3):147-153. PubMed ID: 28601887
    [Abstract] [Full Text] [Related]

  • 2. Alternating Bi-Weekly Intravitreal Ranibizumab and Bevacizumab for Refractory Neovascular Age-Related Macular Degeneration with Pigment Epithelial Detachment.
    Witkin AJ, Rayess N, Garg SJ, Maguire JI, Storey P, Kaiser RS, Hsu J, Vander JF, Ho AC.
    Semin Ophthalmol; 2017; 32(3):309-315. PubMed ID: 26337539
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of outer retinal tubulations in eyes switched from intravitreal ranibizumab to aflibercept for treatment of exudative age-related macular degeneration.
    Massamba N, Dirani A, Butel N, Fardeau C, Bodaghi B, Ingram A, Lehoang P.
    Graefes Arch Clin Exp Ophthalmol; 2017 Jan; 255(1):61-67. PubMed ID: 27397583
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Retinal venular calibre dilatation after intravitreal ranibizumab treatment for neovascular age-related macular degeneration.
    Wickremasinghe SS, Guymer RH, Wong TY, Kawasaki R, Wong W, Qureshi S.
    Clin Exp Ophthalmol; 2012 Jan; 40(1):59-66. PubMed ID: 21668787
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Retinal and choroidal thickness changes after single anti-VEGF injection in neovascular age-related macular degeneration: ranibizumab vs bevacizumab.
    Sizmaz S, Kucukerdonmez C, Kal A, Pinarci EY, Canan H, Yilmaz G.
    Eur J Ophthalmol; 2014 Jan; 24(6):904-10. PubMed ID: 24803153
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. EFFECT OF INTRAVITREAL RANIBIZUMAB ON GANGLION CELL COMPLEX AND PERIPAPILLARY RETINAL NERVE FIBER LAYER IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION USING SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY.
    Zucchiatti I, Cicinelli MV, Parodi MB, Pierro L, Gagliardi M, Accardo A, Bandello F.
    Retina; 2017 Jul; 37(7):1314-1319. PubMed ID: 28574419
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Assessment of Choroidal Topographic Changes by Swept-Source Optical Coherence Tomography After Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration.
    Razavi S, Souied EH, Darvizeh F, Querques G.
    Am J Ophthalmol; 2015 Nov; 160(5):1006-13. PubMed ID: 26275471
    [Abstract] [Full Text] [Related]

  • 15. Influence of Vitreomacular Adhesion on Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration.
    Kanadani TCM, Dos Reis Veloso CE, Dorairaj S, Nehemy MB.
    Ophthalmic Res; 2017 Nov; 58(1):18-26. PubMed ID: 28301850
    [Abstract] [Full Text] [Related]

  • 16. Effects of intravitreal ranibizumab on the untreated eye and systemic gene expression profile in age-related macular degeneration.
    Michalska-Małecka K, Kabiesz A, Kimsa MW, Strzałka-Mrozik B, Formińska-Kapuścik M, Nita M, Mazurek U.
    Clin Interv Aging; 2016 Nov; 11():357-65. PubMed ID: 27069359
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol.
    Berg K, Pedersen TR, Sandvik L, Bragadóttir R.
    Ophthalmology; 2015 Jan; 122(1):146-52. PubMed ID: 25227499
    [Abstract] [Full Text] [Related]

  • 20. Intravitreal therapies for non-neovascular age-related macular degeneration with intraretinal or subretinal fluid.
    Cuesta-Lasso M, Vieira-Barros A, Dolz-Marco R, Roig-Revert MJ, Badal J, Amselem L, Díaz-Llopis M, Gallego-Pinazo R.
    Arch Soc Esp Oftalmol; 2017 Mar; 92(3):101-106. PubMed ID: 27912913
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.